Spotlight

Recent studies highlight the growing interest surrounding the use of IV iron for patients with HFrEF and iron deficiency.

In inflammatory bowel disease, empiric or overall food avoidance increases the risk for food avoidance and avoidant/restrictive food intake disorder.

In Part 2, Dr. Brockway reviews non-pharmacological interventions, such as physical therapy, for pain management in COPD.

Researchers analyzed whether valbenazine’s impact on tardive dyskinesia symptoms varied between patients with schizophrenia versus bipolar disorder.

Patients and clinicians generally report suboptimal disease control at lower rates than those determined by Selecting Therapeutic Targets in IBD-II metrics.

Optimizing pain management strategies can help physicians better support patients with COPD in their journey towards improved health and well-being.

Authors of a recent review outlined barriers to tardive dyskinesia diagnosis and how neurologists and psychiatrists can collaborate to optimize care.

Among the landscape of HF, comorbidities such as anemia and iron deficiency have garnered attention for their potential impact on patient outcomes.

The following is a summary of “Effect of iron deficiency on RV function in acute decompensated...

Iron deficiency anemia is common in patients with Crohn’s disease and ulcerative colitis, but iron supplementation also could be an effective treatment.

Dr. Brockway reviews non-pharmacological interventions, such as physical therapy, for pain management in COPD.

Vitamin E has shown potential for targeting the underlying mechanisms of inflammatory bowel disease, but more research into its clinical application is needed.

Comorbidities complicate COPD management, but the underlying mechanisms driving both conditions present an opportunity for therapeutic advancements.

Only half of patients with metastatic castration-resistant prostate cancer were tested for HRR mutations, and PARP inhibitors were underused.